Clinuvel’s Phototoxicity Drug Scenesse Approved In Third Market

Product Also To Be Studied In Ischemic Stroke

Venetian blinds silhouette with sun ray
People with EPP risk severe adverse reactions if exposed to light • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approvals

More from Product Reviews